Preoperative estimation of remnant hepatic function using fusion images obtained by99mTc-labelled galactosyl-human serum albumin liver scintigraphy and computed tomography

British Journal of Surgery

Volumn 97, Issue 6, 2010, Pages 934-944

  Yumoto, Y ^a   Yagi, T ^b   Sato, S ^c   Nouso, K ^d   Kobayashi, Y ^d   Ohmoto, M ^e   Yumoto, E ^d   Nagaya, I ^c   Nakatsukasa, H ^d  

^a OKAYAMA UNIVERSITY   (Japan)

^b Okayama University   (Japan)

^c Department of Radiology ^*  (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e Saiseikai Imabari Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; DIAGNOSTIC AGENT; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA GALACTOSYL HUMAN SERUM ALBUMIN; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER; LIVER FAILURE; LIVER RESECTION; LIVER TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RADIOGRAPHY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ASIALOGLYCOPROTEIN RECEPTOR; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER FAILURE; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORGAN SIZE; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77952766432     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7025     Document Type: Article

References (44)

1. Arii S, Yamada Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224-1229.
2. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology 1997; 26: 1176-1181. (Pubitemid 27509300)
3. Yumoto Y, Umeda M, Oshima K, Ogawa H, Kurokawa T, Kajitani M et al. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylenetriamine-pentaacetic acid galactosyl human albumin. Cancer Chemother Pharmacol 1.994; 33(Suppl): S1-S6.
4. Stadalnik RC, Vera DR, Woodel ES, Trudeau WL, Porter BA, Krohn KA et al. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med 1985; 26: 1233-1242. (Pubitemid 16020936)
5. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004; 84: 355-373.
6. 99mTc-GSA) liver scintigraphy. Hepatology 1997; 25: 426-429.
7. Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Taketa Y et al. Preoperative evaluation of functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med 1998; 25:1377-1382.
8. Kokudo N, Vera DR, Koizumi M, Seki. M, Sato T, Stadalnik RC et al. Recovery of hepatic asialoglycoprotein receptors after major hepatic resection. J Nucl Med 1999; 40: 137-141. (Pubitemid 29044184)
9. 99mTc-DTPA-galactosyI-human serum albumin dynamic SPECT. J Nucl Med 1999; 40: 1644-1651.
10. Mizumoto R, Kawarada Y, Yamawaki T, Noguchi T, Nishida S. Resectability and functional reserve of the liver with obstructive jaundice in dogs. Am J Surg 1979; 137: 768-772.
11. Madoff DC, Hicks ME, Vauthey JN, Charnsangavej C, Morello FAJr, Ahrar K et al. Transhepatic portal vein embolization: anatomy, indications, and technical considerations Radiographics 2002; 22: 1063-1076.
12. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127:512-519.
13. Vera DR, Stadalnik RC, Trudeau WL, Scheibe PO, Krohn KA. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyI-neogIycoalbumin. J Nucl Med 1991; 32: 1169-1176.
14. Kudo M, Todo A, Ikekubo K, Yamamoto K, Vera DR, Stadalnik RC. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology 1993;17:814-819. (Pubitemid 23150090)
15. Senda K, Tanaka K, Sakuma S. [Evaluation of a counting method for liver volume determination using single photon emission computed tomography.] Kaku Igaku 1984; 21: 279-304.
16. Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Use of technetium 99m diethylenetriamine-pentaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 1995; 117: 429-434.
17. Pimstone NR, Stadalnik RC, Vera DR, Hutak DP, Trudeau WL. Evaluation of hepatocellular function by way of receptor-mediated uptake of a technetium-99m-labeled asialoglycoprotein analog. Hepatology 1994; 20: 917-923.
18. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. 2003. Hepatol Res 2007; 37: 676-691.
19. Vera DR, Stadalnik RC, Metsu CE, Pimstone NP. Diagnostic performance of a receptor binding radiopharmacokinetic model. J Nucl Med 1996; 37: 160-164.
20. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995; 169: 589-594.
21. Heymsfield SB, Fulenwider T, Nordlinger B. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med 1979; 90: 185-187.
22. Yamada I. [The internal organ weight of the Japanese.] The Medical Comprehensive Bulletin 1946; 2: 14-15.
23. 99mTcGSA, a new agent for functional imaging of the liver.] Kaku Igaku 1992; 29: 159-181.
24. Kinoshita H, Sakai K, Iwasa R, Hirohashi K, Kubo S, Fujio N et al. Results of preoperative portal vein embolization for hepatocellular carcinoma. Osaka City Med J 1988; 34: 115-122.
25. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P et al. Preoperative embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521-527. (Pubitemid 20156653)
26. Uhl M, Euringer W, Makowiec F, Adam U, Schneider A, Langer M. [Portal vein embolization preparation for major hepatic resection: a new standard in liver surgery.] Rofo 2007; 179:31-37.
27. Sherlock S, Dooley J. Diseases of the Liver and Biliary System (9th edn). Blackwell Scientific Publications: Oxford, 1993.
28. Kan MK, Hopkins GB. Measurement of liver volume by emission computed tomography. J Nucl Med 1979; 20: 514-520.
29. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
30. Kokudo K, Vera DR, Tada K, Koizumi M, Seid M, Matsubara T et al. Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysis. World J Surg 2002; 26: 1342-1347.
31. Lang H, Radtke A, Hindennach M, Schroeder T, Fruhaüf NR, Malagó M et al. Impact of virtual tumor resection and computer-assisted risk analysis on operation planning and inoperative strategy in major hepatic resection. Arch Surg 2005; 140: 629-638.
32. Dinant S, de Graaf W, Verwer BJ, Bennink RJ, Lienden KP, Gouma DJ et al. Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 2007; 48: 685-692.
33. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J et al. Preoperative portal vein embolization for major liver resection a meta-analysis. Ann Surg 2008; 247: 49-57.
34. Jacobsson H, Jonas E, Hellström PM, Larsson SA. Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients. J Gastroenterol 2005; 40: 733-738. (Pubitemid 41349085)
35. Nagino M, Kamiya J, Nishio H, Ebara T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow up. Ann Surg 2006; 243: 364-372.
36. Krishnamurthy S, Krishnamurthy GT. Technetium99m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology. Hepatology 1989; 9: 139-153. (Pubitemid 19046316)
37. Kudo M, Todo A, Ikebukuro K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepato-cellular damage. AmJ Gastroenterol 1992; 87: 865-870.
38. Zacharia TT. Assessment of future remnant liver regeneration after portal vein embolization using three-dimensional CT and MR volumetric analyses. Aust Radiol 2006; 50: 543-548.
39. Akaki S, Mitsumori A, Kanazawa S, Togami I, Take da Y, Joja I et al. Technetium-99m-DTPA-galactosyI human serum albumin liver scintigraphy evaluation of regional CT/MRI attenuation/signal intensity differences. J Nucl Med 1998;39:529-532.
40. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000; 232: 665-672.
41. Kubota Y, Kitagawa S, Inoue K, Ha-Kawa SK, Kojima M, Tanaka Y. Hepatic functional scintigraphic imaging with 99mtechnetium galactosyl serum albumin. Hepatogastroenterology 1993; 40: 32-36. (Pubitemid 23093920)
42. 99mTc-colloid scintigraphy and liver ultrasonography. Nucl Med Commun 2007; 28: 95-99.
43. Harada H, Imamura H, Miyagawa S, Kawasaki S. Fate of the human liver after hemihepatic portal vein embolization. Hepatology 1997; 26: 1162-1170.
44. 99mTc-GSA hepatic scintigraphy. Ann Nucl Med 1995; 9: 229-235.